Upregulation of connexin 43 protein expression and increased gap junctional communication by water soluble disodium disuccinate astaxanthin derivatives

Cancer Letters

Volumn 211, Issue 1, 2004, Pages 25-37

  Hix, Laura M ^a,b   Lockwood, Samuel F ^b   Bertram, John S ^a  

^a UNIVERSITY OF HAWAII   (United States)

^b HAWAII BIOTECH INC   (United States)

Author keywords

Astaxanthin; Cancer chemoprevention; Carotenoids; Connexin 43; Disodium salt disuccinate astaxanthin derivatives; Gap junctions; Synthetic astaxanthin derivatives

Indexed keywords

ASTAXANTHIN; CONNEXIN 43; DISODIUM DISUCCINATE ASTAXANTHIN DERIVATIVE; LUCIFER YELLOW; SUCCINIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SOLUBILITY; DRUG SYNTHESIS; EMBRYO CELL; FIBROBLAST CULTURE; FISHER EXACT TEST; GAP JUNCTION; IMMUNOCOMPETENT CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; BETA CAROTENE; CELL COMMUNICATION; CELLS, CULTURED; CONNEXIN 43; GAP JUNCTIONS; MICE; SOLUTIONS; UP-REGULATION; XANTHOPHYLLS;

ANIMALIA; MARTES PENNANTI;

EID: 2942519505     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.01.036     Document Type: Article

References (43)

1. Britton G. Structure and properties of carotenoids in relation to function. Fed. Am. Soc. Exp. Biol. J. 9:1995;1551-1558
2. Bertram J.S. Carotenoids and gene regulation. Nutr. Rev. 57:1999;182-191
3. Bertram J.S., Hossain M.Z., Pung A., Rundhaug J.E. Development of in vitro systems for chemoprevention research. Prev. Med. 18:1989;562-575
4. Loewenstein W.R. Junctional intercellular communication and the control of growth. Biochim. Biochim. Biophys. Acta. 560:1979;1-65
5. Mehta P.P., Bertram J.S., Loewenstein W.R. Growth inhibition of transformed cells correlates with their junctional communication with normal cells. Cell. 44:1986;187-196
6. Neveu M., Bertram J.S. Gap junctions and neoplasia. Hertzberg E.L., Bittar E.E. Gap Junctions. 2000;221-262 JAI Press, Greenwich, CT
7. Aust O., Ale-Agha N., Zhang L., Wollersen H., Sies H., Stahl W. Lycopene oxidation product enhances gap junctional communication. Food Chem. Toxicol. 41:2003;1399-1407
8. Bertram J.S., King T.J., Fukushima L., Khachik F. Enhanced activity of an oxidation product of lycopene found in tomato products and human serum relevant to cancer prevention. Sen K.S., Sies H., Baeuerle P.A. Antioxidant and Redox Regulation of Genes. 2000;410-424 Academic Press, San Diego
9. Mehta P.P., Bertram J.S., Loewenstein W.R. The actions of retinoids on cellular growth correlate with their actions on gap junctional communication. J. Cell Biol. 108:1989;1053-1065
10. Hossain M.Z., Wilkens L.R., Mehta P.P., Loewenstein W.R., Bertram J.S. Enhancement of gap junctional communication by retinoids correlates with their ability to inhibit neoplastic transformation. Carcinogenesis. 10:1989;1743-1748
11. Hanusch M., Stahl W., Schulz W.A., Sies H. Induction of gap junctional communication by 4-oxoretinoic acid generated from its precursor canthaxanthin. Arch. Biochem. Biophys. 317:1995;423-428
12. Acevedo P., Bertram J.S. Liarozole potentiates the cancer chemopreventive activity of and the up-regulation of gap junctional communication and connexin 43 expression by retinoic acid and β-carotene in 10T1/2 cells. Carcinogenesis. 16:1995;2215-2222
13. Zhang L.-X., Cooney R.V., Bertram J.S. Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: relationship to their cancer chemopreventive action. Carcinogenesis. 12:1991;2109-2114
14. Zhang L.-X., Cooney R.V., Bertram J.S. Carotenoids up-regulate connexin 43 gene expression independent of their pro-vitamin A or antioxidant properties. Cancer Res. 52:1992;5707-5712
15. Hossain M.Z., Zhang L.-X., Bertram J.S. Retinoids and carotenoids upregulate gap junctional communication: correlation with enhanced growth control and cancer prevention. Hall J.E., Zampighi G.A., Davies R.M. Progess in Cell Research vol. 3: Gap Junctions. 1993;301-309 Elsiever, Amsterdam
16. Cooney R.V., Kappock T.J., Pung A., Bertram J.S. Solubilization, cellular uptake, and activity of β-carotene and other carotenoids as inhibitors of neoplastic transformation in cultured cells. Methods Enzymol. 214:1993;55-68
17. Cardounel A.J., Dumitrescu C., Zweier J.L., Lockwood S.F. Direct superoxide anion scavenging by a disodium disuccinate astaxanthin derivative: relative efficacy of individual stereoisomers versus the statistical mixture of stereoisomers by electron paramagnetic resonance imaging. Biochem. Biophys. Res. Commun. 307:2003;704-712
18. Zsila F., Simonyi M., Lockwood S.F. Interaction of the disodium disuccinate derivative of meso-astaxanthin with human serum albumin: from chiral complexation to self-assembly. Bioorg. Med. Chem. Lett. 13:2003;4093-4100
19. Rogers M., Berestecky J.M., Hossain M.Z., Guo H.M., Kadle R., Nicholson B.J., Bertram J.S. Retinoid-enhanced gap junctional communication is achieved by increased levels of connexin 43 mRNA and protein. Mol. Carcinog. 3:1990;335-343
20. Simonyi M., Bikadi Z., Zsila F., Deli J. Supramolecular exciton chirality of carotenoid aggregates. Chirality. 15:2003;680-698
21. Bikadi Z., Zsila F., Deli J., Mady G., Simonyi M. The supramolecular structure of self-assembly formed by capsanthin derivatives. Enantiomer. 7:2002;67-76
22. Salares V.R., Young N.M., Carey P.R., Bernstein H.J. Excited state (exciton) interactions in polyene aggregates. J. Raman Spectrosc. 6:1977;282-288
23. Bertram J.S. Neoplastic transformation in cell cultures: in vitro/in vivo correlations. Int. Agency Res. Cancer Sci. Pub. 67:1985;77-91
24. Vine A.L., Bertram J.S. Cancer chemoprevention by connexins. Cancer Metastasis Rev. 21:2002;199-216
25. Piechocki M.P., Burk R.D., Ruch R.J. Regulation of connexin 32 and connexin 43 gene expression by DNA methylation in rat liver cells. Carcinogenesis. 20:1999;401-406
26. Mordan L.J., Bertram J.S. Retinoid effects on cell-cell interactions and growth characteristics of normal and carcinogen-treated C3H/10T1/2 cells. Cancer Res. 43:1983;567-571
27. Sakr W., Tabaska P., Kucuk O., Bertram J.S. Differential expression of connexin 43 in normal, preneoplastic and neoplastic squamous epithelium of the upper aerodigestive tract. Proc. Am. Assoc. Cancer Res. 37:1996;269
28. King T.J., Fukushima L.H., Hieber A.D., Shimabukuro K.A., Sakr W.A., Bertram J.S. Reduced levels of connexin 43 in cervical dysplasia: inducible expression in a cervical carcinoma cell line decreases neoplastic potential with implications for tumor progression. Carcinogenesis. 21:2000;1097-1109
29. Omenn G.S., Goodman G., Thornquist M.D., Balmes J., Cullen M.R., Glass A., et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med. 334:1996;1150-1155
30. Heinonen O.P., Albanes D. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med. 330:1994;1029-1035
31. Hennekens C.H., Buring J.E., Manson J.E., Stampfer M., Rosner B., Cook N.R., et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N. Engl. J. Med. 334:1996;1145-1149
32. Mayne S.T., Cartmel B., Baum M., Shor-Posner G., Fallon B.G., Briskin K., et al. Randomized trial of supplemental β-carotene to prevent second head and neck cancer. Cancer Res. 61:2001;1457-1463
33. Liu C., Lian F., Smith D.E., Russell R.M., Wang X.D. Lycopene supplementation inhibits lung squamous metaplasia and induces apoptosis via up-regulating insulin-like growth factor-binding protein 3 in cigarette smoke-exposed ferrets. Cancer Res. 63:2003;3138-3144
34. Burton G.W., Ingold K.U. beta-Carotene: an unusual type of lipid antioxidant. Science. 224:1984;569-573
35. Martin H.D., Jager C., Ruck C., Schmidt M., Walsh R., Paust J. Anti- and prooxidant properties of carotenoids. J. Prakt. Chem. 341:2004;302-308
36. Giovannucci E. A review of epidemiologic studies of tomatoes, lycopene, and prostate cancer. Exp. Biol. Med. (Maywood). 227:2002;852-859
37. Kucuk O., Sarkar F.H., Sakr W., Djuric Z., Pollak M.N., Khachik F., et al. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol. Biomarkers Prev. 10:2001;861-868
38. Nishino H., Jinno K. Prevention of Hepatitis C Virus-induced Liver Cancer by Natural Carotenoids and Vitamin E. Proceedings of Frontiers in Cancer Prevention Research, AACR Conference (October 14-18), Boston. 2002;. p. 107
39. Tanaka T., Morishita Y., Suzui M., Kojima T., Okumura A., Mori H. Chemoprevention of mouse urinary bladder carcinogenesis by the naturally occurring carotenoid astaxanthin. Carcinogenesis. 15:1994;15-19
40. Tanaka T., Makita H., Ohnishi M., Mori H., Satoh K., Hara A. Chemoprevention of rat oral carcinogenesis by naturally occurring xanthophylls, astaxanthin and canthaxarathin. Cancer Res. 55:1995;4059-4064
41. Kurihara H., Koda H., Asami S., Kiso Y., Tanaka T. Contribution of the antioxidative property of astaxanthin to its protective effect on the promotion of cancer metastasis in mice treated with restraint stress. Life Sci. 70:2002;2509-2520
42. Jyonouchi H., Sun S., Iijima K., Gross M.D. Antitumor activity of astaxanthin and its mode of action. Nutr. Cancer. 36:2000;59-65
43. Saez J.C., Martinez A.D., Branes M.C., Gonzalez H.E. Regulation of gap junctions by protein phosphorylation. Braz. J. Med. Biol. Res. 31:1998;593-600